Stocktoria
Baird Medical Investment Holdings Ltd BDMD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-13
Chart by TradingView
1/9
Piotroski F — financial health
0.49
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $22.5M | $37.0M | $31.5M |
| Gross profit | $18.9M | $32.7M | $27.2M |
| Operating income | -$25.6M | $15.3M | $11.9M |
| Net income | -$27.3M | $12.5M | $10.5M |
| Operating cash flow | -$1.3M | -$6.3M | -$1.0M |
| Free cash flow | -$1.4M | -$9.2M | -$3.7M |
| Total assets | $69.7M | $78.0M | $56.7M |
| Total liabilities | $38.5M | $38.2M | $21.0M |
| Shareholders' equity | $31.4M | $39.7M | $35.7M |
| Ratios | |||
| Gross margin | 83.8% | 88.2% | 86.6% |
| Operating margin | -113.7% | 41.4% | 37.7% |
| Net margin | -121.0% | 33.6% | 33.5% |
| FCF margin | -6.2% | -24.8% | -11.6% |
| Return on assets | -39.1% | 16.0% | 18.6% |
| Return on equity | -87.0% | 31.4% | 29.5% |
| Debt / equity | 0.19× | 0.09× | 0.05× |
| Current ratio | 1.70 | 1.77 | 2.11 |
| Revenue growth | -39.2% | 17.7% | — |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.49 (distress)
- Working capital / assets 0.324
- Retained earnings / assets -0.007
- EBIT / assets -0.368
- Equity / liabilities 0.815
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001982444 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.